Yüklüyor......
Octreotide use and safety in infants with hyperinsulinism
BACKGROUND: Octreotide is a synthetic peptide analog of naturally occurring somatostatin. Octreotide is used off-label in children <6 years of age for hyperinsulinism, chylothorax, and gastrointestinal bleeding. There is a lack of controlled data on efficacy or potential adverse events from this...
Kaydedildi:
| Yayımlandı: | Pharmacoepidemiol Drug Saf |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286465/ https://ncbi.nlm.nih.gov/pubmed/27910218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4144 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|